Press release
July 29, 2026
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
HCW Biologics Inc. (HCWB)
MIRAMAR, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to treat autoimmune diseases, cancer and senescence-associated dysplasia, today